Return to Featured

Pharmaceutical

Cancer treatment: Pralatrexate

2009

Cancer treatment: Pralatrexate

FDA approval of treatment for peripheral T-cell lymphoma caps decades of SRI research.

2000s Pharmaceutical Products

Lymphoma treatment: Targretin® (bexarotene)

1999

Lymphoma treatment: Targretin® (bexarotene)

FDA approves treatment for cutaneous T-cell lymphoma.

1990s Firsts Pharmaceutical Products Seminal innovations

Lymphoma treatment: Targretin® (bexarotene)

Human liver tissue bank

1983

Human liver tissue bank

The first human liver tissue bank for testing drugs on humans versus animals.

1980s Pharmaceutical

Blood treatment: Hirudin

1980s

Blood treatment: Hirudin

New treatment for blood clot prevention stems from peptide once only found in leeches.

1980s Pharmaceutical Products Seminal innovations

Blood treatment: Hirudin

Malaria treatment: Halofantrine

1965

Malaria treatment: Halofantrine

Treatment for drug-resistant malaria saves countless lives.

1960s Federal Programs Military Pharmaceutical

Anti-viral: Vidarabine

1960

Anti-viral: Vidarabine

Drug originally intended to fight cancer discovered effective against herpes simplex and varicella zoster viruses.

1960s Firsts Pharmaceutical Products Seminal innovations

Anti-viral: Vidarabine

Cancer research

1956

Cancer research

SRI enters the ranks searching for possible anticancer agents–work that continues today.

1950s Federal Programs Pharmaceutical

How can we help?

Please leave this field empty.

Area of interest

Country

First name

Last name

Company name

Your email address

Your message

Select all that apply(optional)Discovery ServicesPreclinical/Early Clinical Development ServicesPartnership/CollaborationsBasic Research

Once you hit send…

We’ll match your inquiry to the person who can best help you. Expect a response within 48 hours.

Our Privacy Policy

Message Sent

Success! - Thank you for your interest.